ENSAYO DE PCR EN TIEMPO REAL PARA LA GENOTIPIFICACIÓN DE VIRUS DE PAPILOMA HUMANO DE ALTO RIESGO (HPV)
Mexico·Clase II·III. Agentes de
diagnóstico·AXMILAB, S.A. DE C.V.·Registered May 22, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- HIGH-RISK HUMAN PAPILLOMAVIRUS (HPV) GENOTYPING REAL TIME PCR KIT
- Trade Name (English)
- HIGH-RISK HUMAN PAPILLOMAVIRUS (HPV) GENOTYPING REAL TIME PCR KIT
- Analysis ID
- 1489R2024 SSA
- Registration Date
- May 22, 2024
- Name (Spanish)
- AXMILAB, S.A. DE C.V.
- Name (English)
- AXMILAB, S.A. DE C.V.
Access comprehensive regulatory information for ENSAYO DE PCR EN TIEMPO REAL PARA LA GENOTIPIFICACIÓN DE VIRUS DE PAPILOMA HUMANO DE ALTO RIESGO (HPV) (ENSAYO DE PCR EN TIEMPO REAL PARA LA GENOTIPIFICACIÓN DE VIRUS DE PAPILOMA HUMANO DE ALTO RIESGO (HPV)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1489R2024 SSA and manufactured by AXMILAB, S.A. DE C.V.. The device was registered on May 22, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.